Jung Ji Yong, Yoo Kyung Don, Kang Eunjeong, Kang Hee Gyung, Kim Su Hyun, Kim Hyoungnae, Kim Hyo Jin, Park Tae-Jin, Suh Sang Heon, Jeong Jong Cheol, Choi Ji-Young, Hwang Young-Hwan, Choi Miyoung, Kim Yae Lim, Oh Kook-Hwan
Division of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Division of Nephrology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Kidney Res Clin Pract. 2021 Dec;40(4):578-595. doi: 10.23876/j.krcp.21.700. Epub 2021 Dec 10.
The Korean Society of Nephrology (KSN) has published a clinical practice guideline (CPG) document for maintenance hemodialysis (HD). The document, 2021 Clinical Practice Guideline on Optimal HD Treatment, is based on an extensive evidence-oriented review of the benefits of preparation, initiation, and maintenance therapy for HD, with the participation of representative experts from the KSN under the methodologists' support for guideline development. It was intended to help clinicians participating in HD treatment make safer and more effective clinical decisions by providing user-friendly guidelines. We hope that this CPG will be meaningful as a recommendation in practice, but not on a regulatory rule basis, as different approaches and treatments may be used by health care providers depending on the individual patient's condition. This CPG consists of eight sections and 15 key questions. Each begins with statements that are graded by the strength of recommendations and quality of the evidence. Each statement is followed by a summary of the evidence supporting the recommendations. There is also a link to full-text documents and lists of the most important reports so that the readers can read further (most of this is available online).
韩国肾脏病学会(KSN)发布了一份维持性血液透析(HD)的临床实践指南(CPG)文件。该文件《2021年最佳血液透析治疗临床实践指南》基于对血液透析准备、启动和维持治疗益处的广泛循证综述,由KSN的代表专家参与,并在方法学家对指南制定的支持下完成。其目的是通过提供用户友好型指南,帮助参与血液透析治疗的临床医生做出更安全、更有效的临床决策。我们希望本CPG作为实践中的一项建议具有意义,但不作为监管规则依据,因为医疗服务提供者可能会根据个体患者的情况采用不同的方法和治疗方式。本CPG由八个部分和15个关键问题组成。每个部分开头的陈述都根据推荐强度和证据质量进行了分级。每个陈述后面都有支持这些推荐的证据总结。还有全文文件链接和最重要报告列表,以便读者进一步阅读(大部分可在线获取)。